Literature DB >> 8302368

Atherogenesis and fibrinogen: historical perspective and current status.

L Pilgeram1.   

Abstract

A review of 117 research publications describes a deficiency in fatty acid transport into intracellular oxidative energy metabolism which causes increased fibrinogen synthesis and turnover into fibrin. The increased production of fibrin, coupled with depressed activation of plasminogen, increases the fibrin/plasmin ratio causing thrombosis-induced atherogenesis. This discovery unifies the two schools of atherogenesis based on blood lipid or fibrin deposition theories.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302368     DOI: 10.1007/BF01149268

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  83 in total

1.  Susceptibility to experimental atherosclerosis and the methylation of ethanolamine 1,2-C14 to phosphatidyl choline.

Authors:  L O PILGERAM; D M GREENBERG
Journal:  Science       Date:  1954-11-05       Impact factor: 47.728

2.  Oxidative phosphorylation in insect sarcosomes.

Authors:  S E LEWIS; E C SLATER
Journal:  Biochem J       Date:  1954-10       Impact factor: 3.857

3.  Some factors in nuclear stimulation of mitochondrial oxidative phosphorylation in vitro.

Authors:  H STERN; S TIMONEN
Journal:  Exp Cell Res       Date:  1955-08       Impact factor: 3.905

4.  Thrombin mimetic effects of estrogen: II. Gel filtration and centrifugal evidence for estrogen induced polymerization of fibrinogen derivatives.

Authors:  L O Pilgeram; G vom dem Bussche
Journal:  Thromb Res       Date:  1975-01       Impact factor: 3.944

5.  Pathogenesis of atherosclerosis.

Authors:  J B DUGUID
Journal:  Lancet       Date:  1949-11-19       Impact factor: 79.321

6.  The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.

Authors: 
Journal:  JAMA       Date:  1973-11-05       Impact factor: 56.272

7.  Control of fibrinogen biosynthesis: the role of free fatty acid.

Authors:  L O Pilgeram; L R Pickart
Journal:  J Atheroscler Res       Date:  1968 Jan-Feb

8.  Plasma fibrinogen patterns in patients with coronary atherosclerosis.

Authors:  J W Hampton; J Mantooth; E N Brandt; S G Wolf
Journal:  Circulation       Date:  1966-12       Impact factor: 29.690

9.  Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia; studies in normal persons and patients having arteriosclerosis.

Authors:  W J BLOCK; N W BARKER; F D MANN
Journal:  Circulation       Date:  1951-11       Impact factor: 29.690

10.  The stabilization of serum lipid emulsions by serum phospholipids.

Authors:  E H AHRENS; H G KUNKEL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

View more
  2 in total

1.  Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease.

Authors:  H Burgmann; U Hollenstein; T Maca; K Zedwitz-Liebenstein; F Thalhammer; R Koppensteiner; H Ehringer; W Graninger
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

2.  Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.

Authors:  Laurence Pilgeram
Journal:  Cardiovasc Eng       Date:  2010-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.